K. Clinton Cary, MD, MPH

Contact :

kcary@iupui.edu

Testicular cancer patients deserve the highest quality surgical care. Our work strives to understand how to improve outcomes for our patients both inside and outside of the operative room.

Initiatives

Care Delivery

Research Scientist, William M. Tierney Center for Health Services Research, Regenstrief Institute
Associate Professor of Urology, Indiana University School of Medicine

Dr. Clint Cary’s research efforts focus on improving the health of patients with urologic cancers through health services and outcomes research in testis, bladder, and kidney cancer. He recently completed a 5-year study funded by the NIH to assess utilization rates of single-dose intravesical chemotherapy in patients with non-muscle invasive bladder cancer in a population-based environment.

He actively publishes on advanced testicular cancer outcomes in numerous high-impact journals and has authored numerous book chapters on the topic of testicular cancer. He has served as a Visiting Professor both nationally and internationally to disseminate his research findings.

He provides direct medical and surgical care, with a specific focus on patients with testicular cancer and bladder cancer. Dr. Cary serves as the Director of Urologic Oncology Research for the Department of Urology, Director of the Urologic Germ Cell Tumor Program, and a member of the American Urological Association (AUA) Young Urologists Committee.

Featured Projects

Understanding barriers to single-dose intravesical chemotherapy in non-muscle invasive bladder cancer

(NIH/NCI)

Role: Primary Investigator

Determine the barriers to intraoperative intravesical chemotherapy and how to effectively develop and implement interventions to increase translation of this best available evidence into clinical practice.

Highlighted Publications

Feb 2022

Ranking Important Factors for Using Postoperative Chemotherapy in Nonmuscle Invasive Bladder Cancer: Conjoint Analysis Results From the Michigan Urological Surgery Improvement Collaborative (MUSIC)

Publication: Journal of Urology

doi: 10.1097/JU.0000000000002233

Authors: Cary C, Tong Y, Linsell S, Ghani K, Miller DC, Weiner M, Koch MO, Perkins SM, Zimet G

Jun 2021

Longitudinal Health Related Quality of Life After Open Radical Cystectomy: Comparison of Ileal Conduit, Indiana Pouch, and Orthotopic Neobladder

Publication: Urology

doi: 10.1016/j.urology.2020.12.036

Authors: Kern SQ, Speir RW, Tong Y, Kaimakliotis H, Masterson TA, Bihrle R, Foster R, Koch MO, Cary C

Mar 2021

Surgical Management of Retrocrural Disease in Germ Cell Tumors: Outcomes and Evolution of Practice

Publication: Journal of Urology

doi: 10.1097/JU.0000000000001427

Authors: Kern SQ, Cary C, Kaimakliotis HZ, Pedrosa J, Masterson T, Bihrle R, Foster R, Kesler K

Mar 2021

Barriers to single-dose intravesical chemotherapy in non-muscle invasive bladder cancer: what's the problem?

Publication: Urology Practice

doi: 10.1097/upj.0000000000000174

Authors: Cary C, Militello L, DeChant P, Frankel R, Koch MO, Weiner M

Oct 2020

Management of Metastatic Pure Teratoma in Chemotherapy Naive Patients With Testicular Primaries

Publication: American Journal of Clinical Oncology

doi: 10.1097/COC.0000000000000731

Authors: Cary C, Kern SQ, Jacob JM, Calaway AC, Foster RS, Einhorn LH

Aug 2020

Post-chemotherapy retroperitoneal lymph node dissection in patients presenting with very high HCG levels

Publication: Urologic Oncology

doi: 10.1016/j.urolonc.2020.04.024

Authors: Speir RW, Calaway AC, Einhorn LH, Foster RS, Cary C

Jul 2020

Long-Term Oncologic Outcomes after Primary Retroperitoneal Lymph Node Dissection: Minimizing the Need for Adjuvant Chemotherapy

Publication: Journal of Urology

doi: 10.1097/JU.0000000000000792

Authors: Douglawi A, Calaway A, Tachibana I, Panizzutti Barboza M, Speir R, Masterson T, Adra N, Foster R, Einhorn L, Cary C

Apr 2020

Improving postoperative quality of care in germ cell tumor patients: Does scheduled alvimopan, acetaminophen, and gabapentin improve short-term clinical outcomes after retroperitoneal lymph node dissection?

Publication: Urologic Oncology

doi: 10.1016/j.urolonc.2019.12.016

Authors: doi: 10.1016/j.urolonc.2019.12.016

In The News

Influence

Featured Fellowship

People

NewsNational study confirms breakthrough COVID cases are less severe than COVID in unvaccinated adults

NewsRedesigning diabetes technology to detect low blood sugar in older adults with diabetes and Alzheimer’s disease

NewsNew study provides evidence for three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

VideosDr. Tom Imperiale on tailoring colonoscopy screening for 45- to 49-year-olds

VideosDrs. David Haggstrom and Eric Vachon: Personal Health Records for Cancer Survivors

National study confirms breakthrough COVID cases are...

K. Clinton Cary, MD, MPH

Contact :

Initiatives

Featured Projects

Understanding barriers to single-dose intravesical chemotherapy in non-muscle invasive bladder cancer

Highlighted Publications